Sensiclav BD 228.5mg Dry Syrup

USES OF SENSICLAV BD 228.5MG DRY SYRUP IN CHILDREN
Treatment of Resistance Tuberculosis (TB)
Treatment of Bacterial infections
BENEFITS OF SENSICLAV BD 228.5MG DRY SYRUP FOR YOUR CHILD
In Treatment of Resistance Tuberculosis (TB)
In multidrug-resistant (MDR) tuberculosis, the causative bacteria produce an enzyme called beta-lactamase. This enzyme breaks down the antibiotics and makes them ineffective. As a result, the bacteria become resistant to the antibiotic being used for treatment. Sensiclav BD 228.5mg Dry Syrup comprises two active ingredients, amoxycillin and clavulanic acid. While clavulanic acid stops the enzyme from rendering amoxycillin ineffective, amoxycillin works towards killing the tuberculosis-causing bacteria. This makes the combination of amoxycillin and clavulanic acid an effective treatment for resistant tuberculosis.